Molecular Partners Ag (MOLN) Assets (2020 - 2026)

Molecular Partners Ag (MOLN) has reported Assets for 7 consecutive years, with $95.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Assets fell 36.18% year-over-year to $95.8 million in Q2 2026; TTM through Jun 2026 was $95.8 million, a 36.18% decrease from a year earlier, with the FY2025 full-year figure at $123.2 million, down 31.66% from the prior year.
• Assets was $95.8 million for Q2 2026 at Molecular Partners Ag, down from $111.9 million in the prior quarter.
• Over five years, Assets peaked at $337.7 million in Q1 2022 and troughed at $95.8 million in Q2 2026.
• A 5-year average of $208.1 million and a median of $200.7 million in 2024 frame the typical range for Assets.
• Across the five-year window, Assets soared 51.57% in 2022 and tumbled 36.18% in 2026, its largest moves.
• Over 5 years, Assets stood at $272.2 million in 2022, then dropped by 17.86% to $223.6 million in 2023, then decreased by 19.07% to $181.0 million in 2024, then fell by 29.4% to $127.8 million in 2025, then fell by 25.03% to $95.8 million in 2026.
• The last three Assets figures came in at $95.8 million (Q2 2026), $111.9 million (Q1 2026), and $127.8 million (Q4 2025), per Business Quant data.